FibroBiologics Wins European Patent for Cancer Fibroblasts
The European Patent Office granted patent EP 4454709 covering fibroblast-based delivery of tumour-inhibiting agents.
Houston Cancer News
For readers in Houston, this page covers clinical trials, treatment advances, screening guidelines, new drug approvals and environmental research. Reporting follows local research developments and the adoption of national care standards.
Recent news
November 6, 2026
MD Anderson Plans $3.4 Billion Houston ExpansionThe Houston cancer center will add a 25-story tower and a radiation oncology building in the Texas Medical Center.
October 30, 2026
Moleculin Finishes Dosing for AML Clinical Trial PartThe Houston-based firm completed patient dosing for the first phase of its trial testing Annamycin for leukemia treatment.
October 25, 2026
Cindy Banda Shares Breast Cancer Treatment JourneyA Houston-area patient reflects on her mastectomy and ongoing medical recovery.
October 22, 2026
MD Anderson Uses AI to Track Cancer Treatment ResistanceResearchers employed an RNA foundation model to map biological states linked to drug resistance in metastatic colorectal cancer.
October 21, 2026
Houston Girl Receives Bone Marrow From SisterA seven-year-old girl in Houston is recovering after a successful bone marrow transplant performed by her sister.
October 20, 2026
Harris Health Approves New Houston Cancer CenterThe $150 million project will expand oncology services at the John M. O'Quinn Hospital campus in Northeast Houston.
October 13, 2026
Houston PAP Project Expanded Cervical Cancer ScreeningThe local health initiative provides free screenings to women to combat higher cancer rates among the Hispanic community.
October 9, 2026
Nurse Shared Personal Journey With NeurofibromatosisVictoria McClosky discussed living with neurofibromatosis type 1 at a 2026 nursing summit in Houston.
October 7, 2026
OnVagus Received Approval for Cancer Device TrialThe Houston-based clinical study will test a nerve-stimulation device for patients suffering from cachexia.
October 7, 2026
Rockets Social Media Manager Announced Cancer DiagnosisHannah Peery has scheduled surgery and launched a fundraising effort for the MD Anderson Boot Walk.
More in Cancer
Houston reporting spans clinical trial outcomes, public health screening guidelines, pharmaceutical breakthroughs and institutional research initiatives. Coverage reaches across the city and the communities around it where patients receive care and participate in studies. The proximity to large medical research centers creates a specific pattern of early access to novel treatment protocols and clinical investigations. Federal regulatory changes regarding drug approval often drive the most frequent updates, as researchers work to translate new findings into common practice.